Inventor · disambiguated record
R. Michael Blaese
Also filed as: BLAESE R MICHAEL
10 granted patents·2 pending applications·1,889 citations·filing 1988–2003
91Inventor score
Top patents by PatentIndex Score
12 records- 0198US5399346AGene therapyUS ARMY·Filed 1994·Granted Mar 21, 1995·1.7k cites·14 claims
- 0283US5358866ACytosine deaminase negative selection system for gene transfer techniques and therapiesUS HEALTH·Filed 1991·Granted Oct 25, 1994·69 cites·6 claims
- 0382US5624830ACytosine deaminase negative selection system for gene transfer techniques and therapiesUS HEALTH·Filed 1994·Granted Apr 29, 1997·47 cites·6 claims
- 0480USRE39788EGene therapyUS HEALTH·Filed 2003·Granted Aug 21, 2007·8 cites·20 claims
- 0546US6238858B1Transgenomic virusesUS HEALTH·Filed 1998·Granted May 29, 2001·7 cites·39 claims
- 0645US2003229910A1Short fragment homologous replacement to provide BSE resistant cattleFiled 2003·Application pending·0 cites
- 0742US6984379B1Gene therapy by administration of genetically engineered CD34+ cells obtained from cord bloodUS HEALTH·Filed 1994·Granted Jan 10, 2006·12 cites·16 claims
- 0840US5114973AMethod for treating autoimmune disease using succinylacetoneUS HEALTH·Filed 1988·Granted May 19, 1992·9 cites·14 claims
- 0934US6929917B2Method for cloning of a rare, specifically mutated cellPREGENTIS·Filed 2002·Granted Aug 16, 2005·0 cites·27 claims
- 1033US5104898AMethod of preventing graft rejection in solid organ transplantationUS HEALTH·Filed 1989·Granted Apr 14, 1992·1 cites·20 claims
- 1129US2002034495A1Gene therapyFiled 1994·Application pending·0 cites
- 1227US6045789ABystander effect tumoricidal therapy by expressing an HSV-tk geneUS HEALTH·Filed 1994·Granted Apr 4, 2000·4 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →